About PreOmics
PreOmics is a company based in Munchen (Germany) founded in 2014 by Nils Kulak.. PreOmics has raised $19.14 million across 7 funding rounds from investors including Bruker, EIT Health and European Union. The company has 22 employees as of December 31, 2020. PreOmics offers products and services including iST Kit, BeatBox, APP96, ENRICH-iST, and PreON. PreOmics operates in a competitive market with competitors including PrognomiQ, LenioBio, Vivostat, Expedeon and List Biological Laboratories, among others.
- Headquarter Munchen, Germany
- Employees 22 as on 31 Dec, 2020
- Founders Nils Kulak
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Preomics Gmbh
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19.14 M (USD)
in 7 rounds
-
Latest Funding Round
$15.41 M (USD), Series B
Jan 18, 2022
-
Investors
Bruker
& 6 more
-
Employee Count
22
as on Dec 31, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of PreOmics
PreOmics offers a comprehensive portfolio of products and services, including iST Kit, BeatBox, APP96, ENRICH-iST, and PreON. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Kit for preparing protein samples for mass spectrometry analysis
Device for fast and reproducible tissue and cell homogenization
System for high-throughput automated sample preparation
Kit for enriching low-abundance proteins in plasma and serum
Fully automated system for iST kit workflows
Unlock access to complete
Funding Insights of PreOmics
PreOmics has successfully raised a total of $19.14M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $15.41 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $15.4M
- First Round First Round
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2022 | Amount | Series B - PreOmics | Valuation | Bruker |
|
| Aug, 2019 | Amount | Grant - PreOmics | Valuation |
investors |
|
| May, 2019 | Amount | Grant - PreOmics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in PreOmics
PreOmics has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Bruker, EIT Health and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Early-stage tech & life sciences focused VC firm investing in geographies such as Europe
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by PreOmics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - PreOmics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Preomics Comparisons
Competitors of PreOmics
PreOmics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, LenioBio, Vivostat, Expedeon and List Biological Laboratories, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of tests for the detection and treatment of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
Kits for cell-free eukaryotic protein expression are provided.
|
|
| domain | founded_year | HQ Location |
On-site fibrin sealant preparation systems are developed and provided.
|
|
| domain | founded_year | HQ Location |
Reagents and kits for protein-based research are developed and supplied.
|
|
| domain | founded_year | HQ Location |
Specializes in the production of research reagents
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Preomics
Frequently Asked Questions about PreOmics
When was PreOmics founded?
PreOmics was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is PreOmics located?
PreOmics is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Who is the current CEO of PreOmics?
Nils Kulak is the current CEO of PreOmics. They have also founded this company.
Is PreOmics a funded company?
PreOmics is a funded company, having raised a total of $19.14M across 7 funding rounds to date. The company's 1st funding round was a Grant of $56K, raised on Jun 01, 2015.
How many employees does PreOmics have?
As of Dec 31, 2020, the latest employee count at PreOmics is 22.
What does PreOmics do?
PreOmics was founded in 2014 in Munich, Germany, and operates within the proteomics research sector. Sample preparation kits for reproducible peptide mixtures from various starting materials are manufactured, along with accessories for proteomics workflows. A nano-flow automated peptide pre-fractionation device named SPIDER is currently under development as the companys next innovation.
Who are the top competitors of PreOmics?
What products or services does PreOmics offer?
PreOmics offers iST Kit, BeatBox, APP96, ENRICH-iST, and PreON.
Who are PreOmics's investors?
PreOmics has 7 investors. Key investors include Bruker, EIT Health, European Union, EIC Fund, and Think.Health.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.